abatacept, Orencia
Title: abatacept, OrenciaCategory: MedicationsCreated: 2/8/2006 12:00:00 AMLast Editorial Review: 4/7/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - April 7, 2015 Category: Drugs & Pharmacology Source Type: news

RA Remission May Hold Steady After Stopping Abatacept (CME/CE)
(MedPage Today) -- Remission predicted by HAQ-DI score or C-reactive protein at baseline. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - April 3, 2015 Category: Geriatrics Source Type: news

Evaluating Drug-free Remission With Abatacept in Early RAEvaluating Drug-free Remission With Abatacept in Early RA
Does the addition of abatacept to MTX therapy help achieve drug-free remission in early rheumatoid arthritis? Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 17, 2015 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Lower Maintenance Abatacept Dose Maintains RA Remissions (CME/CE)
(MedPage Today) -- Even half doses help RA patients maintain reduced disease activity (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - January 16, 2015 Category: Geriatrics Source Type: news

Psoriatic Arthritis: Biomarkers May Predict Drug Response Psoriatic Arthritis: Biomarkers May Predict Drug Response
A 1-step test of 57 synovial tissue proteins may predict which patients with psoriatic arthritis would benefit from adalimumab or abatacept. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Durable Drug-Free Remission Possible for RADurable Drug-Free Remission Possible for RA
Some adults with active rheumatoid arthritis (RA) achieved drug-free remission at 12 months after first-line treatment with abatacept, and a proportion remained drug-free up to 18 months. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 23, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Orencia Combo Tops in Early, Severe RA
PARIS (MedPage Today) -- In a study of patients with poor-prognosis early rheumatoid arthritis, more patients treated with abatacept (Orencia) plus methotrexate were in remission at 1 year than were those on methotrexate alone, a researcher reported here. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 12, 2014 Category: Geriatrics Source Type: news

Effectiveness of Abatacept for RA in Europe and CanadaEffectiveness of Abatacept for RA in Europe and Canada
IV abatacept may be a safe and effective therapeutic option for patients with moderate-to-severe rheumatoid arthritis. BMC Musculoskeletal Disorders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 4, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Orencia Aids Beta Cell Function (CME/CE)
(MedPage Today) -- Immune modulation with abatacept (Orencia) helped slow the decline of beta cell function in patients with recent-onset type 1 diabetes even after the treatment stopped, researchers reported. (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 4, 2013 Category: Endocrinology Source Type: news

Orencia Slows Proteinuria in Renal Disease (CME/CE)
ATLANTA (MedPage Today) -- Proteinuria resolved partly or completely in a small group of patients with focal segmental glomerulosclerosis treated with abatacept, according to a study reported here. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 9, 2013 Category: Primary Care Source Type: news

Kidney Week 2013: New clinical trials reveal insights on treating patients with kidney disease
(American Society of Nephrology) An investigational drug called ZS-9 demonstrated promising Phase 2 clinical trial results for treating abnormally high potassium levels in patients with chronic kidney disease.The immune drug abatacept did not provide benefits above standard treatment for patients with kidney inflammation caused by lupus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 9, 2013 Category: Global & Universal Source Type: news

Arthritis Drug Could Benefit Some Kidney Disease Patients
Orencia may help treat a form of kidney disease that often leads to organ failure, study suggests Source: HealthDay Related MedlinePlus Pages: Kidney Diseases, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 8, 2013 Category: Consumer Health News Source Type: news

Repurposed drug may be first targeted treatment for serious kidney disease
(Massachusetts General Hospital) A team led by Massachusetts General Hospital researchers is reporting that treatment with abatacept appeared to halt the course of focal segmental glomerulosclerosis in five patients, preventing four from losing transplanted kidneys and achieving disease remission in the fifth. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2013 Category: Global & Universal Source Type: news

SMC recommendation of self-injection formulation of abatacept
The Scottish Medicines Consortium (SMC) has announced that abatacept solution for subcutaneous injection (Orencia® SC) has been accepted for use within NHS Scotland, in combination with methotrexate (MTX), as a first-line biologic agent for adults with severe rheumatoid arthritis (RA), after failure with conventional disease modifying anti-rheumatic drugs (DMARDs). (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 13, 2013 Category: Drugs & Pharmacology Source Type: news

Abatacept, Adalimumab Equal Head-to-Head for RA at 2 YearsAbatacept, Adalimumab Equal Head-to-Head for RA at 2 Years
The first head-to-head comparison of 2 biologics showed comparable efficacy for the 2 commonly used drugs. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 14, 2013 Category: Consumer Health News Tags: Rheumatology News Source Type: news